← All organizations

Jubilant Innovation Ltd.

For profitContributed to NMEWebsite ↗

Also known as: JUBILANT CADISTA | JUBILANT GENERICS | Jubilant HollisterStier LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

May 15, 2026

Timeline

1920s

Mar 13, 1924
bee venom— NDA Organization

1970s

Jun 1, 1978
Jubilant Innovation Ltd.— Founded
Jun 1, 1978
Jubilant Industries— Acquired

2000s

Jun 1, 2005
Cadista— Acquired

2010s

Sep 30, 2016
rubidium chloride rb-82— NDA Secondary Org

2020s

Apr 11, 2025
deferasirox— Marketing Organization

Drugs by trial phase (10 distinct, 10 trials)

Phase 2 (2 own, 6 via acquisition)

Other trials (0 own, 2 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 6 total across the full acquisition tree)

Recent trials (2)

NCT01149434CollaboratorPhase 1/Phase 2Sep 1, 2010
NCT00842335Lead sponsorPhase 1/Phase 2Feb 1, 2009

Details

Founded: Noida, IN Jun 1, 1978
Last known activity: May 15, 2026